Takeda Pharmaceutical Co Stock Price Prediction
| TKPHF Stock | USD 26.52 0.53 1.96% |
Oversold Vs Overbought
27
Oversold | Overbought |
Takeda Pharmaceutical stock price prediction is an act of determining the future value of Takeda Pharmaceutical shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Takeda Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Takeda Pharmaceutical and does not consider all of the tangible or intangible factors available from Takeda Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Takeda Pharmaceutical Co, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether pink sheet price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Takeda Pharmaceutical based on different types of headlines from major news networks to social media. The Takeda stock price prediction module provides an analysis of price elasticity to changes in media outlook on Takeda Pharmaceutical over a specific investment horizon. Using Takeda Pharmaceutical hype-based prediction, you can estimate the value of Takeda Pharmaceutical Co from the perspective of Takeda Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Takeda Pharmaceutical. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Takeda Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Takeda because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Takeda Pharmaceutical after-hype prediction price | USD 26.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Takeda |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Takeda Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Takeda Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Takeda Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Takeda Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Takeda Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Takeda Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Takeda Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Takeda Pharmaceutical's historical news coverage. Takeda Pharmaceutical's after-hype downside and upside margins for the prediction period are 24.84 and 28.20, respectively. We have considered Takeda Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Takeda Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Takeda Pharmaceutical is based on 3 months time horizon.
Takeda Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Takeda Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Takeda Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Takeda Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 1.68 | 0.00 | 0.01 | 0 Events / Month | 4 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
26.52 | 26.52 | 0.00 |
|
Takeda Pharmaceutical Hype Timeline
Takeda Pharmaceutical is at this time traded for 26.52. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Takeda is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.12%. %. The volatility of related hype on Takeda Pharmaceutical is about 2507.46%, with the expected price after the next announcement by competition of 26.51. About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.58. The entity last dividend was issued on the 30th of March 2023. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections.Takeda Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Takeda Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Takeda Pharmaceutical's future price movements. Getting to know how Takeda Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Takeda Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMMP | Immutep Ltd ADR | 0.13 | 2 per month | 0.00 | (0.05) | 5.56 | (5.33) | 18.34 | |
| HFBL | Home Federal Bancorp | 0.13 | 9 per month | 0.00 | (0.15) | 3.92 | (3.87) | 11.57 | |
| MRKR | Marker Therapeutics | (0.03) | 5 per month | 0.00 | (0.05) | 5.82 | (6.30) | 17.17 | |
| BWMX | Betterware De Mexico | (0.14) | 8 per month | 1.83 | 0.21 | 5.55 | (2.55) | 16.47 | |
| FORTY | Formula Systems 1985 | (0.60) | 8 per month | 1.62 | 0.08 | 5.60 | (3.66) | 13.53 | |
| PVBC | Provident Bancorp | (0.02) | 6 per month | 0.00 | (0.24) | 3.01 | (3.22) | 10.45 | |
| MRSN | Mersana Therapeutics | (0.14) | 7 per month | 4.80 | 0.07 | 9.93 | (9.15) | 30.55 | |
| NRDBY | Nordea Bank Abp | 0.00 | 0 per month | 0.00 | (0.09) | 1.97 | (2.12) | 10.67 | |
| CFX | Conflux Network | 0.00 | 0 per month | 7.80 | 0.05 | 13.64 | (14.29) | 46.05 | |
| C-PN | Citigroup Capital XIII | 0.00 | 0 per month | 0.47 | (0.01) | 0.51 | (0.64) | 5.08 |
Takeda Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Takeda price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Takeda using various technical indicators. When you analyze Takeda charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Takeda Pharmaceutical Predictive Indicators
The successful prediction of Takeda Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Takeda Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical based on analysis of Takeda Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Takeda Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Takeda Pharmaceutical's related companies. Story Coverage note for Takeda Pharmaceutical
The number of cover stories for Takeda Pharmaceutical depends on current market conditions and Takeda Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Takeda Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Takeda Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Takeda Pharmaceutical Short Properties
Takeda Pharmaceutical's future price predictability will typically decrease when Takeda Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Takeda Pharmaceutical Co often depends not only on the future outlook of the potential Takeda Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Takeda Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B |
Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |